Krsnaa Diagnostics Limited

BSE: 543328 NSE: KRSNAA
Krsnaa Diagnostics Limited - healthcare in Pune, Maharashtra, India. FY 2026 financials & compliance.
CIN L74900PN2010PLC138068 Incorporated 22 December 2010 ROC Pune HQ Pune, Maharashtra, India
Active Listed - NSE: KRSNAA · BSE: 543328 Public Limited Company healthcare
Data last updated
Market Cap
₹1,615 Cr
KRSNAA · NSE
Share Price
₹503.75
+1.16% today
Revenue
₹773 Cr
FY 2025-26 · +6.8% YoY
EBITDA
₹212 Cr
Margin 27.4%
Net Profit
₹101 Cr
FY 2025-26 · +36.8% YoY
P/E (TTM)
16.5x
P/B 1.6x
Authorised capital
₹147.16 Cr
Registered with MCA
Paid-up capital
₹16.22 Cr
Issued & subscribed

About Krsnaa Diagnostics Limited

Data last updated:

Krsnaa Diagnostics Limited is a public limited company based in Pune, Maharashtra, India. It operates in the other hospital and medical care activities segment of the healthcare sector. It was incorporated on 22 December 2010 and has been in existence for over 16 years.

The company is registered with the Registrar of Companies (ROC), Pune, under CIN L74900PN2010PLC138068. Its GSTIN is 27AAECK2179H2ZD (Maharashtra). The company holds 3 GST registrations, of which 2 are active. It is a listed company as per MCA records. Its shares are listed on BSE: 543328 and NSE: KRSNAA.

The company has an authorised share capital of ₹147.16 Cr and a paid-up capital of ₹16.22 Cr. It was formerly known as Krsnaa Diagnostics Private Limited and Krsna Diagnostics Private Limited. It is led by directors including Yash Prithviraj Mutha (Managing Director) and Rajendra Khivraj Mutha (Whole-Time Director).

Its last annual general meeting (AGM) was held on 25 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Pune, Maharashtra.

As per the latest consolidated financials for FY 2025-26, the company reported a revenue of ₹772.77 Cr, a growth of 6.8% compared to the previous year. For the same year it recorded a net profit of ₹101.44 Cr (net margin 13.1%) and EBITDA of ₹211.8 Cr (EBITDA margin 27.4%). The net worth stands at ₹980.39 Cr (up 11.1% YoY). Total assets are valued at ₹1,584.52 Cr (up 42.8% YoY).

The company has about 3,582 employees on its provident fund (EPFO) records. Its group structure includes 7 subsidiaries.

The company is associated with 1 brand: Krsnaa Diagnostics. As per MCA filings, the company has open charges of ₹832.76 Cr and satisfied charges of ₹388.35 Cr on record. Court records list 50 cases involving the company, including 34 filed by the company and 16 filed against it; 7 cases are pending. The company has 20 deals on record (7 secondary share transfers, 6 market trades, 6 funding rounds), with disclosed funding of ₹186.06 Cr; the latest was in June 2026. Its 3 peer companies in the Healthcare industry (Diagnostics and Pathology Labs), with the same principal business activity (other hospital and medical care activities) are compared by revenue, 2 larger and 1 smaller; the largest is Lifenity Health Limited with revenue of ₹1,945.64 Cr. The company has 10 MSME Form 1 returns on record between 2019 and 2024, listing 265 overdue payments to 41 micro and small suppliers.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website krsnaa.in.

Company details

CIN L74900PN2010PLC138068
Registration Number 138068
Incorporation Date 22 December 2010
ROC Pune
Listing Status Listed - Listed on NSE (KRSNAA); Listed on BSE (543328)
Company Status Active
Date of Last AGM 25 September 2025
Date of Balance Sheet 31 March 2026
Compliance Status Active Compliant

Name history

Krsnaa Diagnostics has undergone 2 name changes throughout its history. The company was previously known as Krsnaa Diagnostics Private Limited, and Krsna Diagnostics Private Limited. The current legal name is Krsnaa Diagnostics Limited.

Company NameStatus
Krsnaa Diagnostics LimitedCurrent
Krsnaa Diagnostics Private LimitedPrevious
Krsna Diagnostics Private LimitedPrevious

CIN history

Krsnaa Diagnostics has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L74900PN2010PLC138068, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
L74900PN2010PLC138068Current
U74900PN2010PTC138068Previous
U74900PN2010PLC138068Previous
Key People
Yash Prithviraj Mutha Managing Director Rajendra Khivraj Mutha Whole-Time Director Adesh Kumar Gupta Director

Contact details

Krsnaa Diagnostics Limited's registered office is in Pune, Maharashtra. Its website is krsnaa.in. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
    krsnaa.in
  • Social Media
  • Apps
  • Registered Address
    S. No. 243/A Hissa No. 6 Cts No. 4519 4519/1 Near Chinchwad Station Chinchwad Taluk, A – Haveli, Pune, Maharashtra, India – 411019
  • Industry
    Healthcare, Other Hospital And Medical Care Activities

To see the full contact details of Krsnaa Diagnostics Limited, buy the company report.

Comprehensive company report
Krsnaa Diagnostics Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Krsnaa Diagnostics operates one associated brand: Krsnaa Diagnostics. Each brand links to its own profile.

BrandDescriptionWebsite
Krsnaa Diagnostics
Chain of radiology & pathology laboratory centerskrsnaadiagnostics.com

Business activity

The main business activity of Krsnaa Diagnostics is hospital and medical care. In detail, this covers other hospital and medical care activities.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
QHospital and Medical CareQ6Other Hospital and Medical Care Activities

To see the full business activity and turnover split of Krsnaa Diagnostics Limited, buy the company report.

Financials of Krsnaa Diagnostics Limited

FY 2025-26 filings available

Krsnaa Diagnostics Limited reported revenue of ₹772.77 Cr (up 6.8% YoY) for FY 2025-26.

Financial Highlights

FY 2025-26 · Consolidated
Revenue
₹773 Cr
+6.8% YoY
EBITDA
₹212 Cr
+11.4% YoY
Profit After Tax
₹101 Cr
+36.8% YoY
Net Worth
₹980 Cr
+11.1% YoY
Total Assets
₹1,585 Cr
+42.8% YoY
Total Debt
₹534 Cr
+162.5% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2016-17FY 2015-16
Income statement
Revenue77372462548745561.0239.14
Revenue growth+6.8%+15.8%+28.3%+7.0%-+55.9%-
EBITDA21219014412213118.618.87
EBITDA margin+27.4%+26.3%+23.1%+25.1%+28.9%+30.5%+22.7%
Profit before tax13010370.0080.2086.500.09(3.29)
Net profit10174.1356.8761.9768.58(0.09)(4.88)
Net profit margin+13.1%+10.2%+9.1%+12.7%+15.1%-0.2%-12.5%
EPS (₹)30.8824.0317.6019.7821.780.000.00
Balance sheet
Total assets1,5851,110992806755155160
Net worth98088381073968475.7260.92
Total debt53420416032.4840.9936.7880.97
Cash & bank36168.441751092427.2037.72
Net working capital529265258132221(11.67)30.35
Cash flow
Cash from operations14387.3324.3576.3012864.02(22.55)
Cash from investing(396)(99.61)(129)(109)(241)(53.98)(46.53)
Cash from financing27913.7584.19(33.15)176(40.57)105
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue236193181206193186175186
Revenue growth (YoY)+22.1%+3.5%+3.8%+10.6%+13.4%---
Other income7.2531.503.774.183.964.399.244.59
EBITDA57.9854.8746.3659.1551.4052.9945.0749.40
EBITDA margin+24.6%+28.5%+25.6%+28.7%+26.6%+28.5%+25.8%+26.5%
Depreciation27.9622.5922.6623.5921.6321.9622.7022.20
Interest14.8312.087.798.196.306.816.136.39
Profit before tax22.4451.7019.6831.5527.4328.6125.4825.40
Tax5.889.994.447.626.907.936.075.81
Net profit16.5641.7115.2423.9320.5320.6819.4119.59
EPS (₹)5.0412.704.667.256.256.285.885.92
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue691686594464455396258
Revenue growth+0.8%+15.4%+28.1%+2.0%+14.7%+53.4%-
EBITDA21319714612413593.81(114)
EBITDA margin+30.8%+28.7%+24.6%+26.8%+29.6%+23.7%-44.2%
Profit before tax13211071.9482.1989.59295(158)
Net profit10379.3358.6063.3770.89185(112)
Net profit margin+14.9%+11.6%+9.9%+13.7%+15.6%+46.7%-43.3%
EPS (₹)31.2625.6518.1420.2322.52284.73(216.83)
Balance sheet
Total assets1,5901,118997810758474558
Net worth992893815742687232(197)
Total debt53120216032.4840.99232231
Cash & bank35667.91175108242153127
Net working capital546276264137224128141
Cash flow
Cash from operations13489.3824.3975.4812911937.81
Cash from investing(391)(102)(129)(109)(241)(67.37)(76.65)
Cash from financing27813.9184.21(33.13)17620.035.78
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue211173159183176175165179
Revenue growth (YoY)+20.0%-0.9%-3.5%+2.3%+7.6%---
Other income7.2131.413.804.214.004.469.294.60
Total expenses154116112125126121117126
EBITDA56.7356.8347.6758.0050.1053.3047.9052.48
EBITDA margin+26.9%+32.8%+29.9%+31.7%+28.5%+30.5%+29.0%+29.4%
Depreciation27.7022.2522.5323.4721.5121.8022.6922.20
Interest14.7211.867.728.126.256.756.136.39
Profit before tax21.5254.1321.2230.6226.3429.2128.3728.49
Tax5.7010.754.737.406.788.156.776.53

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 30 Oct 2026
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue236193181206193186175186
Revenue growth (YoY)+22.1%+3.5%+3.8%+10.6%+13.4%---
Other income7.2531.503.774.183.964.399.244.59
EBITDA57.9854.8746.3659.1551.4052.9945.0749.40
EBITDA margin+24.6%+28.5%+25.6%+28.7%+26.6%+28.5%+25.8%+26.5%
Depreciation27.9622.5922.6623.5921.6321.9622.7022.20
Interest14.8312.087.798.196.306.816.136.39
Profit before tax22.4451.7019.6831.5527.4328.6125.4825.40
Tax5.889.994.447.626.907.936.075.81
Net profit16.5641.7115.2423.9320.5320.6819.4119.59
EPS (₹)5.0412.704.667.256.256.285.885.92
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2016-17FY 2015-16
Revenue77372462548745561.0239.14
Revenue growth+6.8%+15.8%+28.3%+7.0%-+55.9%-
Other income43.3925.5416.8019.3814.912.343.23
Total expenses56153448136532442.4130.27
Employee cost0.0013711174.5654.1512.509.00
EBITDA21219014412213118.618.87
EBITDA margin+27.4%+26.3%+23.1%+25.1%+28.9%+30.5%+22.7%
Depreciation90.4688.3274.5553.7841.3911.586.44
Interest34.3624.6516.497.7018.499.288.95
Profit before tax13010370.0080.2086.500.09(3.29)
Tax28.9325.0813.1718.0918.120.181.61
Net profit10174.1356.8761.9768.58(0.09)(4.88)
Net profit margin+13.1%+10.2%+9.1%+12.7%+15.1%-0.2%-12.5%
EPS (₹)30.8824.0317.6019.7821.780.000.00
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2016-17FY 2015-16
Equity & liabilities
Share capital16.2216.1516.1515.7015.7070.1555.12
Reserves & surplus9648677947236695.575.80
Shareholders' funds (net worth)98088381073968475.7260.92
Minority interest0.000.000.000.000.000.000.00
Secured loans47926.9711.0016.5025.6332.3878.55
Unsecured loans55.1117714915.9815.364.402.42
Total debt53420416032.4840.9936.7880.97
Total liabilities1,5851,110992806755155160
Assets
Gross block1,04297187462749116091.54
Net block65667064747138613174.02
Capital work in progress2082.969.8525.4828.265.7820.05
Investments57.4331.540.290.290.290.570.53
Inventories26.6629.4835.8125.079.170.950.67
Sundry debtors29627817673.1057.8714.118.44
Cash & bank balances36168.441751092427.2037.72
Loans & advances55.4638.8233.9015.9525.223.369.38
Total current assets73841442122333425.6256.21
Total current liabilities20914916490.9911337.2925.86
Net working capital529265258132221(11.67)30.35
Total assets1,5851,110992806755155160
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2016-17FY 2015-16
Opening cash3.852.3822.7288.4524.6837.721.40
Net cash from operating activities14387.3324.3576.3012864.02(22.55)
Net cash from investing activities(396)(99.61)(129)(109)(241)(53.98)(46.53)
Net cash from financing activities27913.7584.19(33.15)176(40.57)105
Net change in cash26.381.47(20.35)(65.73)63.78(30.53)36.33
Closing cash36168.441751092427.2037.72
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2016-17FY 2015-16
Growth
Sales growth+6.8%+15.8%+28.3%+7.0%-+55.9%-
EBITDA growth+11.4%+31.8%+17.9%-7.0%-+109.8%-
PBT growth+27.0%+46.7%-12.7%-7.3%-+9998.0%+9997.0%
Net income growth+36.8%+30.4%-8.2%-9.6%-+98.2%-
Revenue CAGR (3Y)+16.6%+16.7%+117.2%+131.7%---
EBITDA CAGR (3Y)+20.1%+13.1%+97.9%+139.8%---
Profitability & leverage
Net income margin+13.1%+10.7%+9.1%+12.8%+15.0%-0.2%-12.5%
Return on capital employed-+12.1%+9.6%+11.3%+13.9%0.0%0.0%
Return on net worth-+9.2%+7.3%+8.7%+10.0%0.0%0.0%
Debt / equity-0.210.120.050.060.861.33
Long-term debt / equity-0.050.040.040.050.390.53
Interest cover28.3224.2123.6611.2420.53132.01368.31
Efficiency & per share
Fixed asset turnover-0.780.830.870.930.490.43
Inventory turnover-22.1720.5428.4549.6775.3358.42
Debtors turnover-3.195.017.447.875.414.64
EPS (₹)30.8824.0317.6019.7821.780.000.00
Dividend per share (₹)2.002.752.502.752.500.000.00
Book value per share (₹)0.00273.39250.79235.28217.9820.7921.24
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue211173159183176175165179
Revenue growth (YoY)+20.0%-0.9%-3.5%+2.3%+7.6%---
Other income7.2131.413.804.214.004.469.294.60
Total expenses154116112125126121117126
EBITDA56.7356.8347.6758.0050.1053.3047.9052.48
EBITDA margin+26.9%+32.8%+29.9%+31.7%+28.5%+30.5%+29.0%+29.4%
Depreciation27.7022.2522.5323.4721.5121.8022.6922.20
Interest14.7211.867.728.126.256.756.136.39
Profit before tax21.5254.1321.2230.6226.3429.2128.3728.49
Tax5.7010.754.737.406.788.156.776.53
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue691686594464455396258
Revenue growth+0.8%+15.4%+28.1%+2.0%+14.7%+53.4%-
Other income43.4125.6716.8019.4114.9326512.95
Total expenses478489448340320303373
Employee cost0.0011297.5765.6352.7429.9123.13
EBITDA21319714612413593.81(114)
EBITDA margin+30.8%+28.7%+24.6%+26.8%+29.6%+23.7%-44.2%
Depreciation89.7688.1674.5553.7841.3937.4432.41
Interest33.9424.5716.477.6818.4925.9424.66
Profit before tax13211071.9482.1989.59295(158)
Tax29.6526.7913.3818.6818.90111(46.38)
Net profit10379.3358.6063.3770.89185(112)
Net profit margin+14.9%+11.6%+9.9%+13.7%+15.6%+46.7%-43.3%
EPS (₹)31.2625.6518.1420.2322.52284.73(216.83)
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital16.2216.1516.1515.7015.7024920.19
Reserves & surplus967871797724671(17.02)(217)
Shareholders' funds (net worth)992893815742687232(197)
Secured loans49116610716.5025.63213229
Unsecured loans40.6336.0853.0715.9815.3618.752.20
Total debt53120216032.4840.99232231
Total liabilities1,5901,118997810758474558
Assets
Gross block1,036968874627491377308
Net block651668647471386309275
Capital work in progress2082.969.8525.4828.263.729.13
Investments57.5031.620.360.360.360.290.29
Inventories25.6629.4835.8125.079.177.215.07
Sundry debtors30828317874.5559.3175.2961.43
Cash & bank balances35667.91175108242153127
Loans & advances54.6838.5633.8615.9225.5317.4719.85
Total current assets744419422224336253214
Total current liabilities19814315887.0511212572.26
Net working capital546276264137224128141
Total assets1,5901,118997810758474558
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash3.321.8622.1388.3224.68(46.65)(14.52)
Net cash from operating activities13489.3824.3975.4812911937.81
Net cash from investing activities(391)(102)(129)(109)(241)(67.37)(76.65)
Net cash from financing activities27813.9184.21(33.13)17620.035.78
Net change in cash21.731.46(20.27)(66.19)63.6571.32(33.06)
Closing cash25.0567.91175108242153127
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+0.8%+15.4%+28.1%+2.0%+14.7%+53.4%-
EBITDA growth+8.1%+34.6%+17.6%-7.7%+43.4%+182.2%-
PBT growth+20.7%+52.4%-12.5%-8.3%-69.7%+9998.0%-
Net income growth+29.4%+35.4%-7.5%-10.6%-61.7%+265.5%-
Revenue CAGR (3Y)+14.2%+14.7%+14.5%+21.6%+45.8%+91.0%+93.6%
EBITDA CAGR (3Y)+19.6%+13.5%+15.9%-+31.1%+86.3%-
Profitability & leverage
Net income margin+14.9%+12.1%+9.9%+13.7%+15.5%+46.6%-43.3%
Return on capital employed-+12.7%+9.8%+11.5%+17.0%+59.9%0.0%
Return on net worth-+9.7%+7.5%+8.9%+19.7%-204.0%0.0%
Debt / equity-0.210.120.050.3013.270.00
Long-term debt / equity-0.050.040.040.228.800.00
Interest cover27.6322.6523.0010.9019.8546.02-16.82
Efficiency & per share
Fixed asset turnover-0.740.790.831.051.160.87
Inventory turnover-21.0119.5327.1155.5464.5755.70
Debtors turnover-2.974.716.936.765.804.39
EPS (₹)31.2625.6518.1420.2322.52284.73(216.83)
Dividend per share (₹)2.002.752.502.752.500.000.00
Book value per share (₹)0.00274.65251.73235.63218.72(16.20)(410.62)

To see the full year-wise statements and ratios of Krsnaa Diagnostics Limited, buy the company report.

Board of directors of Krsnaa Diagnostics Limited

Krsnaa Diagnostics has 7 current directors and 24 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Adesh Kumar Gupta
Also directs: Grasim Industries Ltd, Anand Rathi Wealth Limited, Krazybee Services Limited and 4 more
Director28 May 20224 Years 5 MonthsCurrent
Rajendra Khivraj Mutha
Also directs: Samyak Seva Foundation
Whole-Time Director22 Dec 201015 Years 10 MonthsCurrent
Chetan Rameshchandra Desai
Also directs: Sula Vineyards Limited, Delta Corp Limited, Ramkrishna Forgings Ltd and 5 more
Director25 Apr 20215 Years 6 MonthsCurrent
Prem PradeepNominee Director08 Oct 20206 Years 0 MonthsCurrent
Yash Prithviraj Mutha
Also directs: KDPL Diagnostics (Ludhiana) Private Limited, KDPL Diagnostics (Amritsar) Private Limited, KDPL Diagnostics (Bathinda) Private Limited and 5 more
Managing Director31 Jan 20197 Years 8 MonthsCurrent
Raju Venkatraman
Also directs: Dollar Shave Club India LLP, Prodapt Solutions Private Limited, Imersive.Io Private Limited and 4 more
Director25 Apr 20260 Years 6 MonthsCurrent
Showing 6 of 7 current directors. View all directors

Peer comparison

Krsnaa Diagnostics Limited is compared with the 3 companies closest to it by revenue in the Healthcare industry (Diagnostics and Pathology Labs), with the same principal business activity (other hospital and medical care activities), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Lifenity Health Limited₹1,945.64 Cr (FY 2025)52.0%Pune, Maharashtra, India
Agilus Diagnostics Limited₹1,432.43 Cr (FY 2025)3.0%Mohali, Punjab, India
Krsnaa Diagnostics Limitedthis company₹772.77 Cr (FY 2026)₹101.44 Cr13.1%6.8%3,582Pune, Maharashtra, India
Carestream Health India Private Limited₹555.57 Cr (FY 2025)1.0%Mumbai, Maharashtra, India

To see the full peer comparison of Krsnaa Diagnostics Limited, buy the company report.

Auditor

Krsnaa Diagnostics Limited is audited by MS K A & Associates for the financial year 2024.

Auditor firmFinancial yearFirm registration number
MS K A & AssociatesFY 2024105047W

Shareholding

Shareholding for the quarter ended Sep 2026: promoters hold 27.10%, foreign institutional investors hold 4.30%, domestic institutional investors hold 14.50% and retail and other public shareholders hold 54.10%.

Promoters: 27.10%DII (Domestic Institutional): 14.50%FII (Foreign Institutional): 4.30%Retail & Others: 54.10%
Sep 2026
QUARTER
27.10% Promoters
14.50% DII (Domestic Institutional)
4.30% FII (Foreign Institutional)
54.10% Retail & Others
Promoter holding - history
Now 27.10% · Sep 2026High 27.10% · Dec 2025Low 27.10% · Dec 2025
26%26.8%27.5%28.3%29%Dec 2025Mar 2026Jun 2026Sep 2026Dec 2025: 27.10%Mar 2026: 27.10%Jun 2026: 27.10%Sep 2026: 27.10%27.10%27.10%
Shareholding trend - last 6 quarters
Sep 2026Jun 2026Mar 2026Dec 2025
Promoters27.10%27.10%27.10%27.10%
Public72.90%72.90%72.90%72.90%

Charges & borrowings

Open charges
₹832.76 Cr
Satisfied charges
₹388.35 Cr
Breakdown by lending institutions
Others₹689.00 Cr
Hdfc Bank Limited₹120.00 Cr
Yes Bank Limited₹23.75 Cr
Punjab National Bank₹0.01 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
12 Jan 2026101220230Others₹430 CrOpen
20 Sep 2025101166372Others₹50 CrOpen
11 Nov 2024101007094Hdfc Bank Limited₹120 CrOpen
08 Aug 2024100969095Others₹20 CrOpen
21 Feb 2024100910658Yes Bank Limited₹23.75 CrOpen

To see the full charge records of Krsnaa Diagnostics Limited, buy the company report.

Total charge records: 48 View all charges

Deals & funding

Krsnaa Diagnostics Limited has 20 deals on record (7 secondary share transfers, 6 market trades, 6 funding rounds), with disclosed funding of ₹186.06 Cr; the latest was in June 2026.

Total deals
20
Secondary share transfers
7
Market trades
6
Funding rounds
6
IPO
1
Disclosed funding
₹186.06 Cr

Deals on record (5 of 20)

WhenDealAmountParties
Jun 2026Market trade₹15.13 CrBuyer: HDFC Life Insurance Company Limited
Seller: HDFC Life Insurance Company Limited
Oct 2023Market trade₹10.13 CrBuyer: East Lane Capital LLP
Seller: Medimaze Solutions Private Limited
Sep 2023Market trade₹13.18 CrBuyer: Miv Investment Services Private Limited
Seller: Invesco Mutual Fund
Aug 2021Secondary share transferUndisclosedBuyer: Aditya Birla Sun Life Insurance Company Limited
Aug 2021Market trade₹67.31 CrBuyer: Aditya Birla Sun Life Insurance Company Limited , Alphagrep Securities Private Limited , NK Securities Research Private Limited
Seller: Alphagrep Securities Private Limited , NK Securities Research Private Limited

To see the full deal history of Krsnaa Diagnostics Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

Credit ratings & regulatory alerts

Krsnaa Diagnostics Limited was last rated by Icra on 14 Jan 2022.

Rating agencyRated onRating
Icra14 Jan 2022

To see the full credit ratings and regulatory alerts of Krsnaa Diagnostics Limited, buy the company report.

MSME payment delays

Krsnaa Diagnostics Limited has 10 MSME Form 1 returns on record between 2019 and 2024, listing 265 overdue payments to 41 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 41)

SupplierAmount dueDue sinceReported on
an individual supplier
an individual supplier
Print Master
Alphatech Systems
an individual supplier

To see the full MSME payment records of Krsnaa Diagnostics Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Group structure & subsidiaries

Krsnaa Diagnostics has 7 subsidiary companies. This group structure data is as of FY 2024. The table lists each entity with its relationship and holding.

7
Subsidiary companies
Key subsidiaries
Company NameCINShares held
KDPL Diagnostics (Ludhiana) Private LimitedU85100PN2021PTC199690
KDPL Diagnostics (Amritsar) Private LimitedU85100PN2021PTC199780
KDPL Diagnostics (Bathinda) Private LimitedU85100PN2021PTC199781
KDPL Diagnostics (Jalandhar) Private LimitedU85100PN2021PTC199783
KDPL Diagnostics (Patiala) Private LimitedU85100PN2021PTC199785
KDPL Diagnostics (Sas Nagar) Private LimitedU85110PN2021PTC199787

To see the full group structure of Krsnaa Diagnostics Limited, buy the company report.

Employees & EPFO

Krsnaa Diagnostics Limited has a workforce of 3,582 employees on its EPFO records as of Aug 02, 2025, across 1 active EPFO establishment.

Employee count
3,582
Active EPFO establishments
1
Employee growth
6.45%

GST

Krsnaa Diagnostics has 3 GST registrations: 2 active and 1 cancelled or inactive.

Total GSTINs
3
Active
2
Cancelled / inactive
1
GSTINStateStatusRegistered on
27AAECK2179H2ZDMaharashtraActive21 May 2018
03AAECK2179H1ZOPunjabActive18 Feb 2023

To see the full GST registrations and return filing status of Krsnaa Diagnostics Limited, buy the company report.

Recent activity

Krsnaa Diagnostics Limited has 47 board changes on record since 2010: 29 appointments and 18 cessations. The latest: Lilian Jessie Paul was appointed as Director on 25 Apr 2026.

Appointed
Lilian Jessie Paul was appointed as Director.
Appointed
Raju Venkatraman was appointed as Director.
Filing
Krsnaa Diagnostics Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Pune.
Charges
A charge with Others amounted to Rs. 430.00 Cr with Charge ID 101220230 was registered on 12 Jan 2026.
Charges
A charge with Hdfc Bank Limited of Rs. 120.00 Cr registered on 11 Nov 2024 with Charge ID 101007094 was modified on 08 Oct 2025.
AGM
Krsnaa Diagnostics Limited last Annual general meeting of members was held on 25 Sep 2025 as per latest MCA records.
Charges
A charge with Others amounted to Rs. 50.00 Cr with Charge ID 101166372 was registered on 20 Sep 2025.
Charges
A charge registered on 07 Sep 2017 via Charge ID 100127604 with Others was fully satisfied on 11 Mar 2025.
Charges
A charge registered on 11 Sep 2015 via Charge ID 10614300 with Others was fully satisfied on 11 Mar 2025.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 120.00 Cr with Charge ID 101007094 was registered on 11 Nov 2024.
Charges
A charge registered on 04 Feb 2020 via Charge ID 100337619 with Others was fully satisfied on 19 Sep 2024.
Charges
A charge with Others amounted to Rs. 20.00 Cr with Charge ID 100969095 was registered on 08 Aug 2024.

137 earlier events are in the company report.

News

Krsnaa Diagnostics: Co. Announces Strategic AI Collaboration With Global Radiology AI Innovator Azmed, Creating A Platform For Greater Reporting Efficiency And Scalable Growth
22 Oct 2026 · Exchange Update
KRSNAA Diagnostics: Company Board Greenlights Sale of Diagnostic Equipment Worth Up to ₹120 Crore to Improve Asset Management.
28 Sep 2026 · Exchange Update

Frequently asked questions

Krsnaa Diagnostics is an active public limited company based in Pune, Maharashtra, India. The company works in other hospital and medical care activities, within the healthcare industry. It was incorporated on 22 December 2010 (16+ years old) and is registered under CIN L74900PN2010PLC138068. Listed on BSE: 543328 and NSE: KRSNAA.

Krsnaa Diagnostics reported revenue of ₹772.77 Cr for FY 2025-26 (up 6.8% YoY) based on consolidated financials.

Krsnaa Diagnostics has 7 current directors:

The latest financial statements of Krsnaa Diagnostics on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 25 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Krsnaa Diagnostics is 27AAECK2179H2ZD, registered in Maharashtra. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 03AAECK2179H1ZO (Punjab).

The CIN (Corporate Identification Number) of Krsnaa Diagnostics is L74900PN2010PLC138068. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Yes. Krsnaa Diagnostics is a listed company as per MCA records. Its shares are listed on both BSE (code: 543328) and NSE (symbol: KRSNAA).

Krsnaa Diagnostics has 50 court cases on record: 34 filed by the company and 16 filed against it. 7 are pending. Most are in the high courts.

Krsnaa Diagnostics was incorporated on 22 December 2010, making it 16+ years old. It is registered with the Registrar of Companies, Pune.

Krsnaa Diagnostics has 20 deals on record (7 secondary share transfers, 6 market trades, 6 funding rounds), with disclosed funding of ₹186.06 Cr; the latest was in June 2026.

The peers of Krsnaa Diagnostics by revenue are Lifenity Health Limited, Agilus Diagnostics Limited, Carestream Health India Private Limited, all in the Healthcare industry (Diagnostics and Pathology Labs), with the same principal business activity (other hospital and medical care activities).

Lilian Jessie Paul was appointed as Director on 25 Apr 2026. Raju Venkatraman was appointed as Director on 25 Apr 2026. Prashant Pandurangrao Deshmukh ceased to be CEO on 31 Jul 2024. Krsnaa Diagnostics has 47 board changes on record in total.